Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Lixisenatide requires a functional gut-vagus nerve-brain axis to trigger insulin secretion in controls and type 2 diabetic mice.

Charpentier J, Waget A, Klopp P, Magnan C, Cruciani-Guglielmacci C, Lee SJ, Burcelin R, Grasset E.

Am J Physiol Gastrointest Liver Physiol. 2018 Aug 2. doi: 10.1152/ajpgi.00348.2017. [Epub ahead of print]

PMID:
30070580
2.

Corrupted adipose tissue endogenous myelopoiesis initiates diet-induced metabolic disease.

Luche E, Robert V, Cuminetti V, Pomié C, Sastourné-Arrey Q, Waget A, Arnaud E, Varin A, Labit E, Laharrague P, Burcelin R, Casteilla L, Cousin B.

Elife. 2017 Jun 28;6. pii: e23194. doi: 10.7554/eLife.23194.

3.

Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.

Nicolas S, Blasco-Baque V, Fournel A, Gilleron J, Klopp P, Waget A, Ceppo F, Marlin A, Padmanabhan R, Iacovoni JS, Tercé F, Cani PD, Tanti JF, Burcelin R, Knauf C, Cormont M, Serino M.

Mol Syst Biol. 2017 Mar 16;13(3):921. doi: 10.15252/msb.20167356.

4.

Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia.

Pomié C, Blasco-Baque V, Klopp P, Nicolas S, Waget A, Loubières P, Azalbert V, Puel A, Lopez F, Dray C, Valet P, Lelouvier B, Servant F, Courtney M, Amar J, Burcelin R, Garidou L.

Mol Metab. 2016 Mar 28;5(6):392-403. doi: 10.1016/j.molmet.2016.03.004. eCollection 2016 Jun.

5.

Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice.

Branchereau M, Reichardt F, Loubieres P, Marck P, Waget A, Azalbert V, Colom A, Padmanabhan R, Iacovoni JS, Giry A, Tercé F, Heymes C, Burcelin R, Serino M, Blasco-Baque V.

Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1091-101. doi: 10.1152/ajpgi.00424.2015. Epub 2016 Mar 31.

6.

Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response.

Blasco-Baque V, Garidou L, Pomié C, Escoula Q, Loubieres P, Le Gall-David S, Lemaitre M, Nicolas S, Klopp P, Waget A, Azalbert V, Colom A, Bonnaure-Mallet M, Kemoun P, Serino M, Burcelin R.

Gut. 2017 May;66(5):872-885. doi: 10.1136/gutjnl-2015-309897. Epub 2016 Feb 2.

7.

Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice.

Stenman LK, Waget A, Garret C, Briand F, Burcelin R, Sulpice T, Lahtinen S.

Diabetol Metab Syndr. 2015 Sep 12;7:75. doi: 10.1186/s13098-015-0075-7. eCollection 2015.

8.

The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease.

Garidou L, Pomié C, Klopp P, Waget A, Charpentier J, Aloulou M, Giry A, Serino M, Stenman L, Lahtinen S, Dray C, Iacovoni JS, Courtney M, Collet X, Amar J, Servant F, Lelouvier B, Valet P, Eberl G, Fazilleau N, Douin-Echinard V, Heymes C, Burcelin R.

Cell Metab. 2015 Jul 7;22(1):100-12. doi: 10.1016/j.cmet.2015.06.001.

9.

Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice.

Stenman LK, Waget A, Garret C, Klopp P, Burcelin R, Lahtinen S.

Benef Microbes. 2014 Dec;5(4):437-45. doi: 10.3920/BM2014.0014.

PMID:
25062610
10.

Developmental androgen excess disrupts reproduction and energy homeostasis in adult male mice.

Nohara K, Liu S, Meyers MS, Waget A, Ferron M, Karsenty G, Burcelin R, Mauvais-Jarvis F.

J Endocrinol. 2013 Nov 6;219(3):259-68. doi: 10.1530/JOE-13-0230. Print 2013 Dec.

11.

Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism.

Luche E, Cousin B, Garidou L, Serino M, Waget A, Barreau C, André M, Valet P, Courtney M, Casteilla L, Burcelin R.

Mol Metab. 2013 Jul 4;2(3):281-91. doi: 10.1016/j.molmet.2013.06.005. eCollection 2013.

12.

A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.

Moreno-Navarrete JM, Escoté X, Ortega F, Serino M, Campbell M, Michalski MC, Laville M, Xifra G, Luche E, Domingo P, Sabater M, Pardo G, Waget A, Salvador J, Giralt M, Rodriguez-Hermosa JI, Camps M, Kolditz CI, Viguerie N, Galitzky J, Decaunes P, Ricart W, Frühbeck G, Villarroya F, Mingrone G, Langin D, Zorzano A, Vidal H, Vendrell J, Burcelin R, Vidal-Puig A, Fernández-Real JM.

Diabetologia. 2013 Nov;56(11):2524-37. doi: 10.1007/s00125-013-3015-9. Epub 2013 Aug 21.

PMID:
23963324
13.

Prevention of obesity and insulin resistance by estrogens requires ERα activation function-2 (ERαAF-2), whereas ERαAF-1 is dispensable.

Handgraaf S, Riant E, Fabre A, Waget A, Burcelin R, Lière P, Krust A, Chambon P, Arnal JF, Gourdy P.

Diabetes. 2013 Dec;62(12):4098-108. doi: 10.2337/db13-0282. Epub 2013 Jul 31.

14.

Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice.

Nohara K, Waraich RS, Liu S, Ferron M, Waget A, Meyers MS, Karsenty G, Burcelin R, Mauvais-Jarvis F.

Am J Physiol Endocrinol Metab. 2013 Jun 15;304(12):E1321-30. doi: 10.1152/ajpendo.00620.2012. Epub 2013 Apr 23.

15.

Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.

Girousse A, Tavernier G, Valle C, Moro C, Mejhert N, Dinel AL, Houssier M, Roussel B, Besse-Patin A, Combes M, Mir L, Monbrun L, Bézaire V, Prunet-Marcassus B, Waget A, Vila I, Caspar-Bauguil S, Louche K, Marques MA, Mairal A, Renoud ML, Galitzky J, Holm C, Mouisel E, Thalamas C, Viguerie N, Sulpice T, Burcelin R, Arner P, Langin D.

PLoS Biol. 2013;11(2):e1001485. doi: 10.1371/journal.pbio.1001485. Epub 2013 Feb 19.

16.

Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers.

Moreno-Navarrete JM, Serrano M, Sabater M, Ortega F, Serino M, Pueyo N, Luche E, Waget A, Rodriguez-Hermosa JI, Ricart W, Burcelin R, Fernández-Real JM.

J Nutr Biochem. 2013 Jul;24(7):1266-75. doi: 10.1016/j.jnutbio.2012.10.002. Epub 2013 Jan 17.

PMID:
23333090
17.

Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.

Gomez E, Vercauteren M, Kurtz B, Ouvrard-Pascaud A, Mulder P, Henry JP, Besnier M, Waget A, Hooft Van Huijsduijnen R, Tremblay ML, Burcelin R, Thuillez C, Richard V.

J Mol Cell Cardiol. 2012 Jun;52(6):1257-64. doi: 10.1016/j.yjmcc.2012.03.003. Epub 2012 Mar 15.

PMID:
22446161
18.

Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis.

Sebastián D, Hernández-Alvarez MI, Segalés J, Sorianello E, Muñoz JP, Sala D, Waget A, Liesa M, Paz JC, Gopalacharyulu P, Orešič M, Pich S, Burcelin R, Palacín M, Zorzano A.

Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5523-8. doi: 10.1073/pnas.1108220109. Epub 2012 Mar 16.

19.

Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociates obesity from insulin resistance.

Maris M, Overbergh L, Gysemans C, Waget A, Cardozo AK, Verdrengh E, Cunha JP, Gotoh T, Cnop M, Eizirik DL, Burcelin R, Mathieu C.

Diabetologia. 2012 Apr;55(4):1167-78. doi: 10.1007/s00125-011-2427-7. Epub 2012 Jan 12.

PMID:
22237685
20.

Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance.

Moreno-Navarrete JM, Ortega F, Serino M, Luche E, Waget A, Pardo G, Salvador J, Ricart W, Frühbeck G, Burcelin R, Fernández-Real JM.

Int J Obes (Lond). 2012 Nov;36(11):1442-9. doi: 10.1038/ijo.2011.256. Epub 2011 Dec 20.

PMID:
22184060
21.

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota.

Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C, Waget A, Klopp P, Iacovoni J, Klopp C, Mariette J, Bouchez O, Lluch J, Ouarné F, Monsan P, Valet P, Roques C, Amar J, Bouloumié A, Théodorou V, Burcelin R.

Gut. 2012 Apr;61(4):543-53. doi: 10.1136/gutjnl-2011-301012. Epub 2011 Nov 22.

22.

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermúdez-Humarán LG, Smirnova N, Bergé M, Sulpice T, Lahtinen S, Ouwehand A, Langella P, Rautonen N, Sansonetti PJ, Burcelin R.

EMBO Mol Med. 2011 Sep;3(9):559-72. doi: 10.1002/emmm.201100159. Epub 2011 Aug 3.

23.

CD14 modulates inflammation-driven insulin resistance.

Fernández-Real JM, Pérez del Pulgar S, Luche E, Moreno-Navarrete JM, Waget A, Serino M, Sorianello E, Sánchez-Pla A, Pontaque FC, Vendrell J, Chacón MR, Ricart W, Burcelin R, Zorzano A.

Diabetes. 2011 Aug;60(8):2179-86. doi: 10.2337/db10-1210. Epub 2011 Jun 23.

24.

Lipid-induced peroxidation in the intestine is involved in glucose homeostasis imbalance in mice.

Serino M, Waget A, Marsollier N, Masseboeuf M, Payros G, Kabani C, Denom J, Lacombe A, Thiers JC, Negre-Salvayre A, Luquet S, Burcelin R, Cruciani-Guglielmacci C, Magnan C.

PLoS One. 2011;6(6):e21184. doi: 10.1371/journal.pone.0021184. Epub 2011 Jun 16.

25.

Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control.

Dao TM, Waget A, Klopp P, Serino M, Vachoux C, Pechere L, Drucker DJ, Champion S, Barthélemy S, Barra Y, Burcelin R, Sérée E.

PLoS One. 2011;6(6):e20700. doi: 10.1371/journal.pone.0020700. Epub 2011 Jun 6.

26.

Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.

Waget A, Cabou C, Masseboeuf M, Cattan P, Armanet M, Karaca M, Castel J, Garret C, Payros G, Maida A, Sulpice T, Holst JJ, Drucker DJ, Magnan C, Burcelin R.

Endocrinology. 2011 Aug;152(8):3018-29. doi: 10.1210/en.2011-0286. Epub 2011 Jun 14.

PMID:
21673098
27.

Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity.

Jager J, Corcelle V, Grémeaux T, Laurent K, Waget A, Pagès G, Binétruy B, Le Marchand-Brustel Y, Burcelin R, Bost F, Tanti JF.

Diabetologia. 2011 Jan;54(1):180-9. doi: 10.1007/s00125-010-1944-0. Epub 2010 Oct 15.

PMID:
20953578
28.

Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice.

Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P.

Endocrinology. 2009 May;150(5):2109-17. doi: 10.1210/en.2008-0971. Epub 2009 Jan 22.

PMID:
19164473
29.

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice.

Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buléon M, Cani PD, Attané C, Guigné C, Carpéné C, Burcelin R, Castan-Laurell I, Valet P.

Cell Metab. 2008 Nov;8(5):437-45. doi: 10.1016/j.cmet.2008.10.003.

30.

Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.

Knauf C, Cani PD, Ait-Belgnaoui A, Benani A, Dray C, Cabou C, Colom A, Uldry M, Rastrelli S, Sabatier E, Godet N, Waget A, Pénicaud L, Valet P, Burcelin R.

Endocrinology. 2008 Oct;149(10):4768-77. doi: 10.1210/en.2008-0180. Epub 2008 Jun 12.

PMID:
18556349
31.

Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing.

Knauf C, Cani PD, Kim DH, Iglesias MA, Chabo C, Waget A, Colom A, Rastrelli S, Delzenne NM, Drucker DJ, Seeley RJ, Burcelin R.

Diabetes. 2008 Oct;57(10):2603-12. doi: 10.2337/db07-1788. Epub 2008 Jun 2.

32.

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.

Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R.

Diabetes. 2008 Jun;57(6):1470-81. doi: 10.2337/db07-1403. Epub 2008 Feb 27.

33.

Metabolic endotoxemia initiates obesity and insulin resistance.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R.

Diabetes. 2007 Jul;56(7):1761-72. Epub 2007 Apr 24.

34.

Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.

Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, Bueno L, Bucala R, Fioramonti J.

Gastroenterology. 2007 Mar;132(3):982-93. Epub 2006 Dec 17.

PMID:
17324399
35.

Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain.

Knauf C, Rieusset J, Foretz M, Cani PD, Uldry M, Hosokawa M, Martinez E, Bringart M, Waget A, Kersten S, Desvergne B, Gremlich S, Wahli W, Seydoux J, Delzenne NM, Thorens B, Burcelin R.

Endocrinology. 2006 Sep;147(9):4067-78. Epub 2006 Jun 15.

PMID:
16777972
36.

Supplemental Content

Support Center